Mitchell Stephen Ray's Form 4 filing
Vanda Pharmaceuticals Inc. (VNDA) · filed Sep 13, 2021
- Accession no.
- 0001209191-21-055685
- Filed
- Sep 13, 2021
- Trade date
- Sep 9, 2021
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $319.9K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mitchell Stephen RayCIK 0001802653 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 9, 2021 | Common Stock | MOption exerciseAcquired | +5,985 | $10.57 | +$63,261.45 | 15,200 | Direct | |
| Sep 9, 2021 | Common Stock | MOption exerciseAcquired | +13,124 | $12.70 | +$166,674.8 | 28,324 | Direct | |
| Sep 9, 2021 | Common Stock | SSaleDisposed | −19,109 | $16.74 | −$319,884.66 | 9,215 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 9, 2021 | Common Stock | MOption exerciseDisposed | −5,985 | $0.00 | $0 | 0 | Direct | |
| Sep 9, 2021 | Common Stock | MOption exerciseDisposed | −13,124 | $0.00 | $0 | 21,876 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.